Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What do patients with diabetes know about their tablets?

D L Browne1, L Avery, B C Turner

  • 1Bournemouth Diabetes and Endocrine Centre, Royal Bournemouth Hospital, UK.

Diabetic Medicine : a Journal of the British Diabetic Association
|September 6, 2000
PubMed
Summary

Patient and healthcare professional knowledge of oral hypoglycaemic agents is poor, impacting diabetes management. Improved education and clear advice are crucial for better understanding and medication adherence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

External Validation of a CT-Based Radiogenomics Model for the Detection of EGFR Mutation in NSCLC and the Impact of Prevalence in Model Building by Using Synthetic Minority Over Sampling (SMOTE): Lessons Learned.

Academic radiology·2025
Same author

Contrast Enhanced CT Radiogenomics in a Retrospective NSCLC Cohort: Models, Attempted Validation of a Published Model and the Relevance of the Clinical Context.

Academic radiology·2024
Same author

Service user perspectives on social prescribing services for mental health in the UK: a systematic review.

Perspectives in public health·2023
Same author

<sup>1</sup>H NMR metabolic profiling of synovial fluid from patients with anterior cruciate ligament tears and hemarthrosis.

Osteoarthritis and cartilage·2023
Same author

Systematic development and feasibility testing of a multibehavioural digital prehabilitation intervention for patients approaching major surgery (iPREPWELL): A study protocol.

PloS one·2022
Same author

CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial.

ESMO open·2022

Area of Science:

  • Endocrinology and Diabetes Management
  • Pharmacology and Therapeutics
  • Patient Education and Adherence

Background:

  • Oral hypoglycaemic agents are cornerstone therapies for Type 2 diabetes mellitus.
  • Effective management relies on patient and healthcare professional understanding of these medications.
  • Gaps in knowledge can lead to suboptimal treatment outcomes and adherence issues.

Purpose of the Study:

  • To evaluate patient and non-specialist healthcare professional knowledge regarding oral hypoglycaemic agents.
  • To identify specific areas of misunderstanding concerning medication mechanisms, usage, and side effects.

Main Methods:

  • An anonymous questionnaire was administered to 261 patients with Type 2 diabetes and 102 healthcare professionals across two centers.

Related Experiment Videos

  • Data collected included patient demographics, medication details, and knowledge assessment on oral hypoglycaemic agents.

    • Main Results:

    • A significant deficit in patient knowledge was observed regarding medication mechanisms (15%), correct usage relative to food (62%), and potential side effects like hypoglycaemia (10% for sulphonylureas) and gastrointestinal issues (20% for metformin).
    • Medication adherence was suboptimal, with 20% of patients forgetting doses and 5% omitting them due to hyperglycaemia concerns.
    • Healthcare professionals also demonstrated knowledge gaps, particularly concerning dosage timing and mechanisms of action for specific drugs like metformin and acarbose.
    • Patient recall of medication advice was low (35%), with minimal written information provided (1%).

    Conclusions:

    • Both patients and healthcare professionals exhibit poor understanding of oral hypoglycaemic agents.
    • Enhanced patient education and clear prescribing advice are essential to improve comprehension and medication compliance.
    • Community pharmacists are well-positioned to reinforce medication information and support patients.